Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases
Authors:
- Pedro Paulo Teixeira e Silva TorresPTPedro Paulo Teixeira e Silva Torres
- Marcelo Fouad RabahiMRMarcelo Fouad Rabahi
- Maria Auxiliadora do Carmo MoreiraMMMaria Auxiliadora do Carmo Moreira
- Dante Luiz EscuissatoDEDante Luiz Escuissato
- Gustavo de Souza Portes MeirellesGMGustavo de Souza Portes Meirelles
- Edson MarchioriEMEdson Marchiori
Open Access
- 18 June 2021
- journal article
- review article
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 47 (3) , e20200096
Abstract
Many conditions result in chronic interstitial lung disease (ILD), being classified as fibrosing ILDs, including idiopathic pulmonary fibrosis, connective tissue diseases, sarcoidosis, and fibrotic hypersensitivity pneumonitis. HRCT plays an important role in the clinical evaluation of fibrosing ILDs. Current treatment perspectives are encouraging and reinforce the need for HRCT scans of adequate technical quality for early detection of fibrosing ILD. Despite efforts in this regard, the significance and management of imaging findings of early interstitial lung abnormalities have yet to be clarified. After identification of CT findings consistent with fibrosing ILD, radiologists must be able to identify characteristic morphological patterns and, in some cases, features of specific clinical entities. In cases in which HRCT features are not sufficiently specific for a definitive diagnosis, HRCT can aid in selecting the best site for surgical lung biopsy. CT follow-up is useful for identifying progressive fibrosing ILDs and detecting complications unrelated to the underlying disease, including infections, acute exacerbations, and neoplasms. Automated quantification tools have clinical applicability and are likely to be available for use in imaging analysis in the near future. In addition, incorporation of CT evaluation into scoring systems based on clinical and functional parameters for staging fibrosing disease is likely to become valuable in determining prognosis. Knowledge of the clinical applications of CT evaluation is essential for specialists managing patients with fibrosing ILD and can have a positive impact on the clinical course of the disease.Keywords
This publication has 53 references indexed in Scilit:
- Highlights of HRCT imaging in IPFRespiratory Research, 2013
- Subclinical Interstitial Lung Disease: Why You Should CareAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Cryptogenic Organizing Pneumonia: Serial High-Resolution CT Findings in 22 PatientsAmerican Journal of Roentgenology, 2010
- Consenso brasileiro ilustrado sobre a terminologia dos descritores e padrões fundamentais da TC de tóraxJornal Brasileiro de Pneumologia, 2010
- Interstitial lung disease guidelineThorax, 2008
- Idiopathic Nonspecific Interstitial PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Fleischner Society: Glossary of Terms for Thoracic ImagingRadiology, 2008
- High-Resolution CT of Asbestosis and Idiopathic Pulmonary FibrosisAmerican Journal of Roentgenology, 2003
- American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial PneumoniasAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Mixed Infiltrative and Obstructive Disease on High-Resolution CTJournal of Thoracic Imaging, 2001